NIH Clinical Center: Search the Studies

Search the Studies

20 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
000686-CH	Intrathecal 2-Hydroxypropyl-Beta-Cyclodextrin for Neurological Decline in Patients with Niemann-Pick Disease Type C1	Participants currently recruited/enrolled	18-125 Years	NICHD	Excess
000344-DK	Natural History Study of Parathyroid Disorders	Participants currently recruited/enrolled	0-125 Years	NIDDK	Excess
000310-CH	A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human	Recruitment has not started	18-125 Years	NICHD	Excess
000297-CH	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment	Participants currently recruited/enrolled	18-125 Years	NICHD	Excess
20-N-0019	The Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing's Disease	Participants currently recruited/enrolled	18-125 Years	NINDS	Excess
19-CH-0071	An Open-Label Phase 3 Study of the Safety and Efficacy of Pegvisomant in Children with Growth Hormone Excess	Participants currently recruited/enrolled	2-18 Years	NICHD	Excess
17-DK-0013	Therapeutic Targets in African-American Youth with Type 2 Diabetes	Participants currently recruited/enrolled	12-25 Years	NIDDK	Excess
15-AA-0031	Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) during Sleep and Wakefulness	Completed Study; data analyses ongoing	18-60 Years	NIAAA	Apparent
14-CH-0028	Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients with Ectopic Cushing Syndrome	Participants currently recruited/enrolled	18-80 Years	NICHD	Excess
14-AA-0192	Brain Inflammation and Function in Alcoholism	Completed Study; data analyses ongoing	30-75 Years	NIAAA	Excess
11-CH-0078	Evaluation of Cortisol Resistance in Young Endurance-Trained and Elderly Men	Completed Study; data analyses ongoing	18-30 Years	NICHD	Mineralocorticoid
09-I-0200	A Phase I Study of MozobilTM in the Treatment of Patients with WHIMS	Participants currently recruited/enrolled	18-75 Years	NIAID	Excess
09-DK-0223	Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy	Participants currently recruited/enrolled	18-125 Years	NIDDK	Excess
08-DK-0173	A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy	Completed Study; data analyses ongoing	40-80 Years	NIDDK	Excess
07-CH-0008	Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion	Completed Study; data analyses ongoing	18-85 Years	NICHD	Excess
06-CH-0011	Natural History Study of Patients with Excess Androgen	Participants currently recruited/enrolled	0-99 Years	NICHD	Excess
03-H-0282	Characterization of Cardiac Function in Subjects with Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I	Completed Study; data analyses ongoing	21-125 Years	NHLBI	Excess
02-I-0277	Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells	Participants currently recruited/enrolled	0-80 Years	NIAID	Excess
01-CC-0045	Studies of Phlebotomy Therapy in Hereditary Hemochromatosis	Participants currently recruited/enrolled	18-125 Years	CC	Excess
94-I-0079	Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans	Participants currently recruited/enrolled	1-100 Years	NIAID	Apparent